Trial Profile
A Study to Evaluate the Efficacy and Safety of Combination of Oral and Parenteral Vinorelbine with Cisplatin or Carboplatin in Patients With Non Small Cell Lung Cancer (NSCLC)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2016
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Vinorelbine (Primary) ; Vinorelbine (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms SWITCH
- 18 Jan 2016 New trial record